More efficient vaporization by the 200-W Thulium laser system than by the GreenLight high-performance system (HPS) 120-W system

Masatake Shinohara , Yoshihiko Hirao , Kiyohide Fujimoto , Toshihisa Saka

Mini-invasive Surgery ›› 2022, Vol. 6 ›› Issue (1) : 48

PDF
Mini-invasive Surgery ›› 2022, Vol. 6 ›› Issue (1) :48 DOI: 10.20517/2574-1225.2022.47
Original Article

More efficient vaporization by the 200-W Thulium laser system than by the GreenLight high-performance system (HPS) 120-W system

Author information +
History +
PDF

Abstract

Aim: We retrospectively compared and evaluated the safety, efficacy, and 1-year outcomes of 200-W Thulium laser vaporization of the prostate (ThuVAP) and the GreenLight high-performance system (HPS) 120-W system for benign prostatic hyperplasia (BPH).

Methods: Between February 2019 and December 2021, 137 patients with lower urinary tract symptoms secondary to BPH underwent ThuVAP. Between October 2014 and April 2019, 233 patients underwent GreenLight HPS 120-W vaporization of the prostate (HPS-PVP). Prostate-specific antigen (PSA) levels, International Prostate Symptom Scores (IPSS), quality of life (QOL) scores, overactive bladder symptom scores (OABSS), post-void residual (PVR), and maximum flow rates (Qmax) were evaluated before and 1, 3, 6, and 12 months after surgery.

Results: Mean ages in the ThuVAP and HPS-PVP groups were 73.7 and 73.4 years, respectively. Prostate volumes (PV) were 77.0 and 61.4 mL (P < 0.001), respectively. Significant improvements were observed in IPSS, QOL scores, OABSS, Qmax, and PVR in both groups 1 to 12 months after surgery. Laser and hospitalization times were significantly shorter and approximate tissue removal (ΔPV) was significantly larger in the ThuVAP group than in the HPS-PVP group (means, 49.4 min vs. 62.5 min, P < 0.001, means, 4.9 days vs. 5.4 days, P = 0.007, means, 50.4 mL vs. 27.8 mL, P < 0.001, respectively). Vaporization efficiency (ΔPV/laser time) was > 2-fold higher in the ThuVAP group than in the HPS-PVP group (1.1 mL/min vs. 0.5 mL/min). There were significantly fewer postoperative complications in the ThuVAP group than in the HPS-PVP group (13.9% vs. 23.6%, P = 0.030).

Conclusion: Both procedures are safe and useful for BPH obstruction. Based on shorter operating and hospitalization times, fewer complications, and more efficient tissue removal, ThuVAP is a more favorable and effective treatment than HPS-PVP.

Keywords

Benign prostate hyperplasia / thulium laser vaporization / GreenLight HPS 120-W system / prostate surgery / prostate vaporization

Cite this article

Download citation ▾
Masatake Shinohara, Yoshihiko Hirao, Kiyohide Fujimoto, Toshihisa Saka. More efficient vaporization by the 200-W Thulium laser system than by the GreenLight high-performance system (HPS) 120-W system. Mini-invasive Surgery, 2022, 6(1): 48 DOI:10.20517/2574-1225.2022.47

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Schwartz RN,Sadri I.Reasons to believe in vaporization: a review of the benefits of photo-selective and transurethral vaporization.World J Urol2021;39:2263-8

[2]

Brassetti A,Delongchamps NB,Porpiglia F.Green light vaporization of the prostate: is it an adult technique?.Minerva Urol Nefrol2017;69:109-18

[3]

Xia S,Lu J.Thulium laser resection of prostate-tangerine technique in treatment of benign prostate hyperplasia.Zhonghua Yi Xue Za Zhi2005;85:3225-8.

[4]

Fried NM.High-power thulium fiber laser ablation of urinary tissues at 1.94 microm.J Endourol2005;19:25-31

[5]

Gross AJ,Knipper S,Bach T.Complications and early postoperative outcome in 1080 patients after thulium vapoenucleation of the prostate: results at a single institution.Eur Urol2013;63:859-67

[6]

Sun F,Cui D.Long-term results of thulium laser resection of the prostate: a prospective study at multiple centers.World J Urol2015;33:503-8

[7]

Iacono F,Di Lauro G.Efficacy and safety profile of a novel technique, ThuLEP (Thulium laser enucleation of the prostate) for the treatment of benign prostate hypertrophy. Our experience on 148 patients.BMC Surg2012;12 Suppl 1:S21 PMCID:PMC3499280

[8]

Pariser JJ,Pearce SM.High-power thulium laser vaporization of the prostate: short-term outcomes of safety and effectiveness.J Endourol2014;28:1357-62

[9]

Dindo D,Clavien PA.Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.Ann Surg2004;240:205-13 PMCID:PMC1360123

[10]

Barbalat Y,Sayegh CI.Evidence of the efficacy and safety of the thulium laser in the treatment of men with benign prostatic obstruction.Ther Adv Urol2016;8:181-91 PMCID:PMC4872189

[11]

Netsch C,Herrmann TR,Gross AJ.Evaluation of the learning curve for Thulium VapoEnucleation of the prostate (ThuVEP) using a mentor-based approach.World J Urol2013;31:1231-8

[12]

Vargas C,Capdevila S.Vaporization of the prostate with 150-w thulium laser: complications with 6-month follow-up.J Endourol2014;28:841-5 PMCID:PMC4074741

[13]

Hueber PA,Liberman D.Midterm outcomes of initial 250 case experience with Green-Light 120 W-HPS photoselective vaporization prostatectomy for benign prostatic hyperplasia: comparison of prostate volumes < 60cc, 60cc-100cc and > 100cc.Can J Urol2012;5:6450-8

PDF

65

Accesses

0

Citation

Detail

Sections
Recommended

/